Table 1 Baseline clinical data
From: Variations in atherosclerosis and remodeling patterns in aorta and carotids
Demographics and risk factors | Carotid (n = 23 Mean ± S.D (Range/dosage or % if possible) | Thoracic (n = 19 Mean ± S.D (Range/dosage or % if possible) | Abdominal (n = 15 Mean ± S.D (Range/dosage or % if possible) | p-value |
|---|---|---|---|---|
Age (years) | 59.4 ± 10.3 (75-27) | 59.8 ± 12.0 (85-35) | 63.2 ± 12.3 (85-35) | ns |
Male sex (%) | 66.7 | 68.4 | 60.0 | ns |
Height (m) | 1.72 ± 0.08 (1.83-1.55) | 1.72 ± 0.10 (1.89-1.55) | 1.70 ± 0.09 (1.83-1.55) | ns |
Weight (kg) | 77.5 ± 16.8 (114-52) | 78.5 ± 17.1 (123-52) | 79.5 ± 16.0 (114-52) | ns |
Body Mass Index (kg/m2) | 26.0 ± 4.9 (39.2-18.9) | 26.3 ± 4.0 (34.5-18.9) | 27.4 ± 5.0 (39.2-18.9) | ns |
Hypertension (%) | 45.0 | 38.9 | 35.7 | ns |
Diabetes (%) | 31.8 | 26.3 | 40.0 | ns |
Smoking status (%) | Â | Â | Â | Â |
Active | 4.5 | 11.1 | 14.3 | ns |
Quit | 45.0 | 38.9 | 28.6 | ns |
Never | 49.5 | 50.0 | 57.1 | ns |
History of CAD (%) | 27.3 | 21.1 | 26.7 | ns |
Hypercholesterolemia (%) | 35.3 | 29.4 | 29.4 | ns |
Statins use (%) | 41.7 | 42.1 | 40.0 | ns |
Statins (type) | Â | Â | Â | Â |
Atorvastatin | 80.0 (5-10) | 87.5 (5-10) | 100.0 (5-40) | ns |
Pravastatin | 10.0 | 12.5 | 0.0 | ns |
Rosuvastatin | 10.0 | 0.0 | 0.0 | ns |
Statins (dosage) | Â | Â | Â | Â |
None | 60.0 | 62.5 | 50.0 | ns |
Low | 40.0 | 37.5 | 33.3 | ns |
High | 0.0 | 0.0 | 16.7 ns | Â |
Total cholesterol (mg/dl) | 189.0 ± 52.2 (122-287) | 191.3 ± 47.3 (122-287) | 186.3 ± 56.2 (122-287) | ns |
LDL cholesterol (mg/dl) | 115.6 ± 42.2 (62-202) | 113.0 ± 41.3 (65-202) | 106.0 ± 50.8 (62-202) | ns |
HDL cholesterol (mg/dl) | 51.6 ± 15.9 (30-86) | 51.3 ± 16.8 (30-86) | 55.9 ± 17.6 (32-86) | ns |
Triglycerides (mg/dl) | 110.6 ± 59.7 (46-234) | 135.9 ± 86.6 (46-335) | 154.4 ± 132.9 (46-500) | ns |